Here’s What’s Really Happening with Canopy Growth Corp (TSX:WEED)

Canopy Growth Corp (TSX:WEED)(NYSE:CGC) has started coming down again after two major dips in the last year, but is it time to buy, sell, or hold on for dear life?

| More on:
Man holding magnifying glass over a document

Image source: Getty Images.

If you’re like me and have been watching Canopy Growth (TSX:WEED)(NYSE:CGC) over the past year, you’re probably pretty dizzy by now.

The stock was on such a great trend, reaching the $70 range, when October hit — and hit hard. As you’re probably aware, share dropped to more than 50% where they once were, leaving investors scrambling.

Then things started to look up again. The stock has rebounded quite a bit, even hitting that $70 mark again. But since then it’s gone back done to just under $60 per share at the time of writing this article. I mean, look at its performance in the last year; if this is a roller-coaster ride, it’s definitely one that’ll make you nearly nauseous.

WEED Chart

WEED data by YCharts.

So, what the heck is going on?

Trying to keep momentum

If you were to look at Canopy’s news section on its website, you’d be even more in the dark on why this company’s stock isn’t on a steady trend upwards. Every few days, the company makes some sort of announcement in the hopes to help shares.

In the past week alone, the company announced a multi-year extraction agreement with HollyWeed Manufacturing & Extracts Inc., acquired AgriNextUSA, a hemp enterprise that will help Canopy expand in the U.S., and “received a cultivation licence from Health Canada for its facility in Fredericton, New Brunswick.” That’s a lot of good news.

On top of those announcements is the company’s latest quarterly earnings report, where it announced tremendous sales gains. There’s also the company’s 5.6 million square feet of cultivation space that will produce more than 500,000 kilograms of cannabis at peak capacity. And, of course, we can’t forget the $5 billion deal with Constellation Brands that’ll help Canopy expand over the long term.

Keyword: long-term

While there’s a lot of good news being reported, it doesn’t really help investors right this minute. Canopy is in the midst of creating a base: acquiring companies, beginning its expansion into the U.S., expanding internationally, creating brand power, and producing as much cannabis as possible.

It’s completely unclear when all of this will be done. It takes a long time to receive licences from both Canada and the U.S. There’s likely going to be a lot of promises of production that then fall short. And while acquiring the mom-and-pop pot shops is all well and good, that costs money. It’s going to take a lot of money to buy out everyone that could get in Canopy’s way, from a popular shop in Denver to a thriving hemp producer in Alberta.

So, if you own this stock or are wondering whether today’s price is near the bottom, what should you do?

Buy? Sell? Hold?

You’ll notice below that I own this stock, so I obviously want it to do well. However, I’m also looking for the best opportunity to either get out at top dollar or buy more to make more.

To be honest, I see this stock going down even further. While the company is reinvesting in its business, that means it’s draining its (albeit immense) cash supply. Over the next year or so, I wouldn’t be surprised if the company started reporting a few losses while they get themselves set up with their ambitious goals.

However, I’m definitely not selling any time soon. When I bought Canopy, it was as an investment. An exciting investment, yes, with some major moves at the beginning. But now that the dust has settled, I believe this stock has the chance to be the best.

With that in mind, I’ll be holding onto this stock for years to come and waiting for another opportunity to buy a few more shares when those earnings reports come in.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe owns shares of Canopy Growth.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »